A study of the chemical and biological stability of vasoactive intestinal peptide

Drug Development and Industrial Pharmacy

Volumn 39, Issue 12, 2013, Pages 1907-1910

  Cui, Xu ^a   Cao, Deying ^a   Qu, Changhai ^b   Zhang, Xiaoyan ^c   Zheng, Aiping ^c  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^c Beijing Institute of Toxicology and Pharmacology   (China)

Author keywords

Artificial gastric fluid; Artificial intestinal fluid; Oral administration; Stability; Vasoactive intestinal peptide

Indexed keywords

ACID; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; CRYOPRESERVATION; DRUG STABILITY; FREEZING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTESTINE FLUID; IONIC STRENGTH; PH; STOMACH JUICE; TEMPERATURE; THEORY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; DRUG STORAGE; GASTRIC JUICE; HYDROGEN-ION CONCENTRATION; INTESTINAL SECRETIONS; OSMOLAR CONCENTRATION; TEMPERATURE; TIME FACTORS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 84887217085     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2012.693503     Document Type: Article

References (6)

1. Stark B, Andreae F, Mosgoeller W, Edetsberger M, Gaubitzer E, Koehler G, Prassl R. (2008). Liposomal vasoactive intestinal peptide for lung application: protection from proteolytic degradation. Eur J Pharm Biopharm, 70:153-164.
2. Sethi V, Onyuksel H, Rubinstein I. (2005). Liposomal vasoactive intestinal peptide. Methods Enzymol, 391:377-395. (Pubitemid 40254046)
3. Stark B, Debbage P, Andreae F, Mosgoeller W, Prassl R. (2007). Association of vasoactive intestinal peptide with polymer-grafted liposomes: structural aspects for pulmonary delivery. Biochim Biophys Acta, 1768:705-714. (Pubitemid 46275600)
4. Dogrukol-Ak D, Banks WA, Tuncel N, Tuncel M. (2003). Passage of vasoactive intestinal peptide across the blood-brain barrier. Peptides, 24:437-444. (Pubitemid 36561216)
5. Brenneman DE, Glazner G, Hill JM, Hauser J, Davidson A, Gozes I. (1998). VIP neurotrophism in the central nervous system: multiple effectors and identification of a femtomolar-acting neuroprotective peptide. Ann N Y Acad Sci, 865:207-212. (Pubitemid 29047829)
6. Dufes C, Gaillard F, Uchegbu IF, Schatzlein AG, Olivier JC, Muller JM. (2004). Glucose-targeted niosomes deliver vasoactive intestinal peptide (VIP) to the brain. Int J Pharm, 285:77-85. (Pubitemid 39361538)